Allied Market Research published a report titled, "Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the global hemodialysis and peritoneal dialysis industry was estimated at $15.68 billion in 2019, and is expected to hit $22.16 billion by 2027, registering a CAGR of 6.0% from 2020 to 2027.
Download Detailed COVID-19 Impact Sample Report at:
https://www.alliedmarketresearch.com/request-sample/3474
Covid-19 scenario-
- The global hemodialysis and peritoneal dialysis market has not been much affected by the outbreak of covid-19, since the rules and regulations pertaining to pandemic have not been imposed on the healthcare sector.
- However, major surgeries such as kidney transplants were postponed during the first phase of the lockdown, thereby influencing the hemodialysis and peritoneal dialysis market to certain extent.
Drivers, restraints, and opportunities-
Increase in incidences of kidney diseases, issues associated with kidney transplants, and surge in prevalence of lifestyle and chronic diseases drive the growth of the global hemodialysis and peritoneal dialysis market. On the other hand, complications in dialysis treatment and reimbursement policy concerns in emerging nations impede the growth to some extent. However, shift in preference of patients for home hemodialysis and rise in improved market strategies by key players are anticipated to pave the way for lucrative opportunities in the coming years.
Asia-Pacific, followed by North America, to dominate in terms of revenue-
Based on geography, Asia-Pacific, followed by North America, held the largest share in 2019, garnering more than two-fifths of the global hemodialysis and peritoneal dialysis market. The same region would also register the fastest CAGR of 7.2% by 2027. Increase in cases of ESRD, CKDs, diabetes, and hypertension, coupled with surge in diagnosis rates in this region are estimated to drive the market growth.
Frontrunners in the industry-
- Fresenius Medical Care AG & Co. KGaA
- Baxter International Inc.
- Nipro Corporation
- B Braun Melsungen Ag
- Nikkiso Co., Ltd.
- Becton
- Dickinson And Company (C. R. Bard, Inc.)
- Cook Group
- Angiodynamics Inc.
- Medtronic PLC
- Asahi Kasei Corp
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
